ahlam1399
02-22-2016, 11:30 AM
Amgen, UCB say osteoporosis drug meets main goal in late-stage trial
(Reuters) - Amgen Inc and Belgium-based UCB SA said on Monday that their osteoporosis drug met all the primary endpoints by reducing the incidence of new vertebral fracture in postme**pausal women with osteoporosis in a late-stage study.
http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/a2.img (http://da.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/ach.img (http://adchoice.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/ach.htm)http://pi.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/a2t.imghttp://pi2.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4dc19bb5/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=aqIJfZNJ7RM:Z9UzUYBOmU4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=aqIJfZNJ7RM:Z9UzUYBOmU4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=aqIJfZNJ7RM:Z9UzUYBOmU4:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=aqIJfZNJ7RM:Z9UzUYBOmU4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=aqIJfZNJ7RM:Z9UzUYBOmU4:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/aqIJfZNJ7RM
(Reuters) - Amgen Inc and Belgium-based UCB SA said on Monday that their osteoporosis drug met all the primary endpoints by reducing the incidence of new vertebral fracture in postme**pausal women with osteoporosis in a late-stage study.
http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/1/rc.img (http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/1/rc.htm)
http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/2/rc.img (http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/2/rc.htm)
http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/3/rc.img (http://rc.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/a2.img (http://da.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/ach.img (http://adchoice.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/ach.htm)http://pi.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/a2t.imghttp://pi2.feedsportal.com/r/247392272139/u/49/f/654207/c/35217/s/4dc19bb5/sc/19/a2t2.imghttp://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/4dc19bb5/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=aqIJfZNJ7RM:Z9UzUYBOmU4:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=aqIJfZNJ7RM:Z9UzUYBOmU4:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=aqIJfZNJ7RM:Z9UzUYBOmU4:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=aqIJfZNJ7RM:Z9UzUYBOmU4:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=aqIJfZNJ7RM:Z9UzUYBOmU4:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/aqIJfZNJ7RM